4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-014623
SVP, Chief Business Officer acquired 47,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mitchener Stephen SVP, Chief Business Officer | 2022-02-28 | Grant or award | +47,250 | 50,546 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mitchener Stephen SVP, Chief Business Officer | 2022-02-28 | Grant or award · Stock Option (right to buy) | +59,400 | 59,400 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…